BIOLASE (NASDAQ:BIOL) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL – Free Report) in a report released on Friday. The brokerage issued a sell rating on the medical technology company’s stock. BIOLASE Stock Down 7.5 % NASDAQ:BIOL opened at $0.01 on Friday. BIOLASE has a 52 week low of $0.02 and a 52 week high of $1.94. […]
More Stories
Foreign Semiconductors to Face Tariff of ‘Approximately 100 Percent’: Trump
By Joseph Lord President Donald Trump announced on Wednesday that tariffs on semiconductors and computer microchips will be as high...
Suspected Fort Stewart Shooter Identified as US Army Sergeant, Officials Say
By Jack Phillips The man suspected of opening fire at Fort Stewart on Wednesday morning and injuring five soldiers was...
What is Library Management System: Top 10 LMS Software
Managing a library manually takes a lot of time, effort, and paperwork. A Library Management System (LMS) solves this problem....
Salish Matter Bio: Age, Height, Net Worth, and Boyfriend
I came across Salish Matter while scrolling through YouTube one day. After seeing her pop up in more videos, I...
Alphabet Inc. (NASDAQ:GOOGL) Stock Holdings Cut by Fiera Capital Corp
Fiera Capital Corp trimmed its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 17.1% during the 1st quarter, according...
Mackenzie Financial Corp Has $984,000 Stock Holdings in First Solar, Inc. (NASDAQ:FSLR)
Mackenzie Financial Corp trimmed its position in shares of First Solar, Inc. (NASDAQ:FSLR – Free Report) by 52.2% during the...